Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-methoxy-3-(1-methylpiperidylidene)di-(2-thienyl)methane Methobromide
2. Sa-504
1. 35035-05-3
2. Sesden; Sa504
3. Sa504
4. Sa-504
5. Chebi:32226
6. Sa 504
7. 8r9e4766v4
8. 3-(di-2-thienylmethylene)-5-methoxy-1,1-dimethyl-piperidinium Bromide
9. Dsstox_cid_3672
10. 3-(dithiophen-2-ylmethylidene)-5-methoxy-1,1-dimethylpiperidin-1-ium;bromide
11. Dsstox_rid_77138
12. Dsstox_gsid_23672
13. Timepidium Bromide [inn:jan]
14. Timepidii Bromidum
15. Bromuro De Timepidio
16. Cas-35035-05-3
17. Bromure De Timepidium
18. Timepidii Bromidum [inn-latin]
19. Sa 50 Y
20. Ncgc00181009-01
21. Bromure De Timepidium [inn-french]
22. Bromuro De Timepidio [inn-spanish]
23. Unii-8r9e4766v4
24. N-methyl-5-methoxy-3-piperidylidenedithienylmethane Methobromide
25. 1,1-dimethyl-5-methoxy-3-(dithien-2-ylmethylene)-piperidinium Bromide
26. Piperidinium, 3-(di-2-thienylmethylene)-5-methoxy-1,1-dimethyl-, Bromide
27. Timepidium Bromide Anhydrous
28. Schembl249151
29. Timepidium Bromide [mi]
30. Chembl2107574
31. Dtxsid4023672
32. Timepidium Bromide [inn]
33. Timepidium Bromide [mart.]
34. Timepidium Bromide [who-dd]
35. Tox21_112659
36. Hy-u00184
37. 3-(dithiophen-2-ylmethylidene)-5-methoxy-1,1-dimethylpiperidin-1-ium Bromide
38. Akos025401441
39. Tox21_112659_1
40. Ac-1667
41. Cs-7261
42. Ncgc00181009-02
43. Ft-0729919
44. A822507
45. Q7806492
46. 3-(di-2-thienylmethylidene)-1,1-dimethyl-5-(methyloxy)piperidinium Bromide
47. 3-(dithiophen-2-ylmethylene)-5-methoxy-1,1-dimethylpiperidinium Bromide
48. 3-(dithiophen-2-ylmethylidene)-5-methoxy-1,1-dimethyl-piperidin-1-ium Bromide
| Molecular Weight | 400.4 g/mol |
|---|---|
| Molecular Formula | C17H22BrNOS2 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 399.03262 g/mol |
| Monoisotopic Mass | 399.03262 g/mol |
| Topological Polar Surface Area | 65.7 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 390 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
A - Alimentary tract and metabolism
A03 - Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AB - Synthetic anticholinergics, quaternary ammonium compounds
A03AB19 - Timepidium bromide
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Timepidium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Timepidium Bromide, including repackagers and relabelers. The FDA regulates Timepidium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Timepidium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Timepidium Bromide supplier is an individual or a company that provides Timepidium Bromide active pharmaceutical ingredient (API) or Timepidium Bromide finished formulations upon request. The Timepidium Bromide suppliers may include Timepidium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Timepidium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Timepidium Bromide Drug Master File in Japan (Timepidium Bromide JDMF) empowers Timepidium Bromide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Timepidium Bromide JDMF during the approval evaluation for pharmaceutical products. At the time of Timepidium Bromide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Timepidium Bromide suppliers with JDMF on PharmaCompass.
Timepidium Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Timepidium Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Timepidium Bromide GMP manufacturer or Timepidium Bromide GMP API supplier for your needs.
A Timepidium Bromide CoA (Certificate of Analysis) is a formal document that attests to Timepidium Bromide's compliance with Timepidium Bromide specifications and serves as a tool for batch-level quality control.
Timepidium Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Timepidium Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Timepidium Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Timepidium Bromide EP), Timepidium Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Timepidium Bromide USP).
LOOKING FOR A SUPPLIER?
